In gastric cancer, recent studies show that high GFPT2 expression correlates with increased tumor invasion and poor patient outcomes [148], while downregulation of GFPT1 in the same cancer type is similarly associated with EMT, invasion, and adverse prognosis [162]. The gene discussed is GFPT1; the disease is neoplasm.